Literature DB >> 39962

Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting.

M S Tsoi, R Storb, S Dobbs, K J Kopecky, E Santos, P L Weiden, E D Thomas.   

Abstract

Forty-four human long-term survivors after marrow transplantation for aplastic anemia or hematologic malignancy were studied for the presence of circulating nonspecific suppressor cells. Twenty-two of the patients were healthy and 22 had mild to moderately severe chronic graft-vs-host disease (GVHD). Patient mononuclear cells (of donor origin) were tested for their ability to suppress the responses of lymphocytes obtained from the respective marrow donors to alloantigens in mixed leukocyte culture (MLC) and/or to concanavalin A (Con A). Tests were carried out between 199 and 2393 (median 376) days after transplantation. Cells from only 1 of 22 patients without chronic GVHD showed suppression of donor cell blastogeneis responses. In contrast, cells from 11 of 22 patients with chronic GVHD showed more than 30% suppression of donor cell responses in MLC and/or to Con A. The finding of suppressor cells was not related to the time of testing after grafting nor to immmunosuppressive therapy. Nonspecific suppressor activity was abrogated by irradiation with 1600 rads in vitro in five of six cases tested. Nonspecific suppressor cells may be one explanation for the severe combined immunodeficiency and the recurrent infectious complications characteristic of patients with chronic GVHD.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39962

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.

Authors:  L G Lum; M C Seigneuret; R Storb
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

2.  Designed transfer of specific immune responses with bone marrow transplantation.

Authors:  A Saxon; R Mitsuyasu; R Stevens; R E Champlin; H Kimata; R P Gale
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

Review 3.  Progress in bone marrow transplantation in man.

Authors:  R P Gale
Journal:  Surv Immunol Res       Date:  1982

4.  Dissociation between onset of natural killer E-rosette forming cells and of T3-positive cells following HLA-mismatched T cell depleted bone marrow transplantation.

Authors:  J P De Villartay; F Le Deist; C Griscelli; A Fischer
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

Review 5.  Immune reconstitution following bone marrow transplantation.

Authors:  U N Verma; A Mazumder
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

Review 6.  The use of concanavalin A to study the immunoregulation of human T cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

7.  Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation.

Authors:  M Izquierdo; M A Balboa; J M Fernández-Rañada; A Figuera; A Torres; A Iriondo; M López-Botet
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

8.  Purification and partial amino acid sequence of suppressive lymphokine from a CD8+ CD57+ human T hybridoma.

Authors:  C P Quan; S Watanabe; F Vuillier; R Pires; T Matsuo; M Stanislawski; J Pillot; J P Bouvet
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

9.  Analysis of different protein kinase C-dependent events in T cells from allogeneic bone marrow transplantation recipients.

Authors:  M A Balboa; M Izquierdo; F Sánchez-Madrid; J M Fernández-Rañada; M López-Botet
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 10.  The pathophysiology of acute graft-versus-host disease.

Authors:  James L M Ferrara; Kenneth R Cooke; Takanori Teshima
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.